PAVmed Inc.
PAVM- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001624326
No open-market purchases or sales by PAVmed Inc. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $5.56M in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding PAVmed Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 26 | 24 | −2 |
| Shares | 753.7K | 952.8K | +199.1K (+26.4%) |
| Value | $3.10M | $2.03M | −$1.07M (−34.5%) |
New holders (3)
Institutions that held PAVmed Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Clear Street Markets LLC | 3,612 | $8.00K | 0.00% |
| CIBC Private Wealth Group, LLC | 836 | $1.71K | 0.00% |
| Newbridge Financial Services Group, Inc. | 134 | $287 | 0.00% |
Sold out (5)
Institutions that held PAVmed Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Susquehanna International Group, LLP | 22,561 | $93.0K |
| UBS Group AG | 6,017 | $24.8K |
| Glassman Wealth Services | 2,319 | $9.55K |
| Rockbridge Investment Management, LCC | 27 | $112 |
| FMR LLC | 1 | $4 |